Cutler Group LP Bridge Bio Pharma, Inc. Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$16.89 - $35.01 $5,067 - $10,503	300 New	300 $7,000
Q1 2023 May 01, 2023	BUY	$7.17 - $18.55 $3,197 - $8,273	446 Added 34.31%	1,746 $28,000
Q4 2022 Feb 07, 2023	SELL	$6.74 - $11.52 $1,348 - $2,304	-200 Reduced 13.33%	1,300 $9,000
Q3 2022 Oct 25, 2022	SELL	$7.94 - $12.36 $3,176 - $4,944	-400 Reduced 21.05%	1,500 $14,000
Q2 2022 Aug 04, 2022	SELL	$5.21 - $12.14 $65,604 - $152,866	-12,592 Reduced 86.89%	1,900 $17,000

Q1 2022 Apr 14, 2022	SELL	$7.34 - $17.16 $110,922 - $259,321	-15,112 Reduced 51.05%	14,492 $147,000
Q4 2021 Jan 18, 2022	BUY	$11.38 - $53.41 $323,237 - $1.52 Million	28,404 Added 2367.0%	29,604 $493,000
Q1 2021 Apr 26, 2021	BUY	$55.47 - $72.35 $23,630 - $30,821	426 Added 55.04%	1,200 $73,000
Q4 2020 Jan 21, 2021	SELL	$38.38 - $71.11 $116,137 - $215,178	-3,026 Reduced 79.63%	774 $55,000
Q1 2020 May 07, 2020	BUY	$16.11 - $36.23 $61,218 - $137,674	3,800 New	3,800 $110,000

285

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.88B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.